IL117759A - 5H, 10H-Imidazo [1, 2-a] indeno [1, 2-e] pyrazin-4-one derivatives their preparation and medications containing them - Google Patents

5H, 10H-Imidazo [1, 2-a] indeno [1, 2-e] pyrazin-4-one derivatives their preparation and medications containing them

Info

Publication number
IL117759A
IL117759A IL11775996A IL11775996A IL117759A IL 117759 A IL117759 A IL 117759A IL 11775996 A IL11775996 A IL 11775996A IL 11775996 A IL11775996 A IL 11775996A IL 117759 A IL117759 A IL 117759A
Authority
IL
Israel
Prior art keywords
indeno
pyrazin
imidazo
derivatives
preparation
Prior art date
Application number
IL11775996A
Other languages
English (en)
Other versions
IL117759A0 (en
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Priority to IL12656496A priority Critical patent/IL126564A/xx
Publication of IL117759A0 publication Critical patent/IL117759A0/xx
Priority to IL12656498A priority patent/IL126564A0/xx
Publication of IL117759A publication Critical patent/IL117759A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Addiction (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL11775996A 1995-04-05 1996-04-01 5H, 10H-Imidazo [1, 2-a] indeno [1, 2-e] pyrazin-4-one derivatives their preparation and medications containing them IL117759A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL12656496A IL126564A (en) 1995-04-05 1996-04-01 1-(1-Oxoindan-2-yl) imidazole-2-carboxylate derivatives
IL12656498A IL126564A0 (en) 1995-04-05 1998-10-14 1-(1-Oxoindan-2-yl) imidazole-2-carboxylate derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9504013A FR2732681B1 (fr) 1995-04-05 1995-04-05 Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant

Publications (2)

Publication Number Publication Date
IL117759A0 IL117759A0 (en) 1996-08-04
IL117759A true IL117759A (en) 1999-06-20

Family

ID=9477764

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11775996A IL117759A (en) 1995-04-05 1996-04-01 5H, 10H-Imidazo [1, 2-a] indeno [1, 2-e] pyrazin-4-one derivatives their preparation and medications containing them

Country Status (27)

Country Link
US (2) US5902803A (xx)
EP (1) EP0820455B1 (xx)
JP (1) JP4014221B2 (xx)
KR (1) KR19980703550A (xx)
CN (1) CN1063180C (xx)
AR (1) AR002983A1 (xx)
AT (1) ATE207923T1 (xx)
AU (1) AU705471B2 (xx)
BG (1) BG62970B1 (xx)
CA (1) CA2215469A1 (xx)
CZ (1) CZ285797B6 (xx)
DE (1) DE69616532T2 (xx)
DK (1) DK0820455T3 (xx)
EA (1) EA000218B1 (xx)
ES (1) ES2166441T3 (xx)
FR (1) FR2732681B1 (xx)
HU (1) HUP9801716A3 (xx)
IL (1) IL117759A (xx)
MX (1) MX9707528A (xx)
NO (1) NO309480B1 (xx)
NZ (1) NZ305899A (xx)
PL (1) PL322621A1 (xx)
PT (1) PT820455E (xx)
SK (1) SK281274B6 (xx)
TW (1) TW492969B (xx)
WO (1) WO1996031511A1 (xx)
ZA (1) ZA962771B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2743366B1 (fr) * 1996-01-10 1998-02-06 Rhone Poulenc Rorer Sa Derives de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one, leur preparation, leurs intermediaires et les medicaments les contenant
US8603980B2 (en) 2007-01-16 2013-12-10 The Johns Hopkins University Glutamate receptor antagonists and methods of use
SG11201908569QA (en) * 2017-03-21 2019-10-30 Arbutus Biopharma Corp Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2696466B1 (fr) * 1992-10-02 1994-11-25 Rhone Poulenc Rorer Sa Dérivés de 5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one, leur préparation et les médicaments les contenant.

Also Published As

Publication number Publication date
BG62970B1 (bg) 2000-12-29
NO974579D0 (no) 1997-10-03
JP4014221B2 (ja) 2007-11-28
NZ305899A (en) 1998-06-26
EA000218B1 (ru) 1998-12-24
DK0820455T3 (da) 2002-02-18
CA2215469A1 (fr) 1996-10-10
HUP9801716A1 (hu) 1998-11-30
ES2166441T3 (es) 2002-04-16
EA199700296A1 (ru) 1998-04-30
KR19980703550A (ko) 1998-11-05
CN1180357A (zh) 1998-04-29
DE69616532D1 (de) 2001-12-06
HUP9801716A3 (en) 1999-05-28
NO309480B1 (no) 2001-02-05
SK281274B6 (sk) 2001-02-12
PL322621A1 (en) 1998-02-02
AR002983A1 (es) 1998-05-27
AU705471B2 (en) 1999-05-20
CZ314097A3 (cs) 1998-01-14
PT820455E (pt) 2002-04-29
CN1063180C (zh) 2001-03-14
TW492969B (en) 2002-07-01
MX9707528A (es) 1997-11-29
WO1996031511A1 (fr) 1996-10-10
EP0820455A1 (fr) 1998-01-28
DE69616532T2 (de) 2002-05-23
ZA962771B (en) 1996-10-11
ATE207923T1 (de) 2001-11-15
FR2732681B1 (fr) 1997-07-04
US5902803A (en) 1999-05-11
EP0820455B1 (fr) 2001-10-31
CZ285797B6 (cs) 1999-11-17
IL117759A0 (en) 1996-08-04
JPH11503144A (ja) 1999-03-23
FR2732681A1 (fr) 1996-10-11
SK133797A3 (en) 1998-03-04
US6057454A (en) 2000-05-02
AU5402996A (en) 1996-10-23
NO974579L (no) 1997-11-26
BG101941A (en) 1998-11-30

Similar Documents

Publication Publication Date Title
IL117621A0 (en) Pyrido [3,2-e] pyrazinones their preparation and pharmaceutical compositions containing them
IL109315A0 (en) 1, 5-benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
AU3450193A (en) 1,5-benzodiazepine derivatives and their use in medicine
HUP9801336A3 (en) 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones and pharmaceutical compositions containing them
HU228234B1 (en) Rapamycin derivatives, pharmaceutical compositions containing them and their use
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
BG98409A (en) 5-member heterocycles, method for their preparation and medicaments containing them
HUP9802937A3 (en) Benzo[g]quuinoline derivatives, pharmaceutical compositions containing them and their use
HUP9801394A3 (en) 6-phenyl-pyrazolo[3,4-d]pyrimidin-4-one derivatives and pharmaceutical compositions containing them
HUP9800466A3 (en) N-acyl-thieno[3,2-b]azepine derivatives, process for their preparation and pharmaceutical compositions containing them
AU1382797A (en) 5h,10h-imidazo{1,2-a}indolo{3,2-e}pyrazine-4-one derivatives, preparation thereof and drugs containing same
IL118485A (en) 5,6-dihydro-9H-pyrazolo¬3,4-c¾-1,2,4-triazolo¬4,3-a¾ pyridines and pharmaceutical compositions containing them
IL110366A0 (en) 1,5-Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
HU9502726D0 (en) [1,2,4]triazolo[4,3-a]qunoxaline derivatives, their preparation and use
AU2141695A (en) Imidazo{1,2-a}pyrazine-4-one derivatives, preparation thereof and drugs containing same
ZA9786B (en) 5H 10h-imidazo [1,2-a]indeno[1,2-e] pyrazin-4-one derivatives their preparation their intermediates and medicaments containing them
HU9500386D0 (en) Benzodiazepine derivatives and pharmaceutical compositions containing them
HUP9602054A3 (en) Benzofuro- and benzothieno[3,2-b]pyridine derivatives, pharmaceutical compositions containing them, and process for the preparation thereof
IL117759A0 (en) 5H, 10H-imidazo [1, 2-a] indeno [1,2-e] pyrazin-4-one derivatives, their preparation and medications containing them
IL110782A0 (en) Benzodiazepine derivatives, their preparation and pharmaceutical compositions containing them
ZA967602B (en) Indeno [1,2-e]pyrazin-4-ones their preparation and medicinal products containing them
AU1382997A (en) 5h,10h-imidazo{1,2-a}indeno{1,2-e}pyrazine-4-one derivatives, preparation thereof and drugs containing same
AU631408B2 (en) Benzazepine and benzothiazepine derivatives
IL122542A0 (en) Spiro Ú2h-1-benzopyran-2,4'-piperidine¾-4(3h)-one derivatives and pharmaceutical compositions containing them
ZA955942B (en) 4-hydroxy-3-phenylindeno[1,2-b]pyridin-2(1H)-one derivatives their preparation and the medicaments containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed